Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

InVivo Therapeutics Holdings Corp. (NVIV)

1.41   -0.02 (-1.4%) 02-22 16:00
Open: 1.44 Pre. Close: 1.43
High: 1.44 Low: 1.39
Volume: 38,248 Market Cap: 14M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.443 - 1.451 1.451 - 1.46
Low: 1.367 - 1.376 1.376 - 1.386
Close: 1.393 - 1.409 1.409 - 1.426

Technical analysis

as of: 2019-02-22 4:45:30 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 1.89     One year: 2.09
Support: Support1: 1.34    Support2: 1.11
Resistance: Resistance1: 1.62    Resistance2: 1.79
Pivot: 1.48
Moving Average: MA(5): 1.43     MA(20): 1.52
MA(100): 1.79     MA(250): 4.46
MACD: MACD(12,26): -0.05     Signal(9): -0.05
Stochastic oscillator: %K(14,3): 23.93     %D(3): 23.34
RSI: RSI(14): 37.97
52-week: High: 24.50  Low: 1.34  Change(%): -88.3
Average Vol(K): 3-Month: 5659  10-Days: 4395

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
NVIV has closed above bottom band by 24.3%. Bollinger Bands are 28.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 17 Jan 2019 21:29:38 Z
Consumer Sector Update for 01/17/2019: FOSL,GOOG,GOOGL,PPG,ADM,SIG

Thu, 17 Jan 2019 19:28:55 Z
Consumer Sector Update for 01/17/2019: PPG,ADM,SIG

Mon, 26 Nov 2018 20:13:00 Z
NVIV Hopes To INSPIRE, SENS Making Sense, TYME To Report Phase 2 Data In Jan.

Thu, 21 Jun 2018 20:11:37 Z
Mid-Afternoon Market Update: Barnes & Noble Education Climbs Following Q4 Results; InVivo Therapeutics Shares Plunge

Thu, 21 Jun 2018 18:41:37 Z
Mid-Day Market Update: Dow Down Over 150 Points; CASI Pharmaceuticals Shares Spike Higher

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 9.31
Shares Float (M)
% Held by Insiders
% Held by Institutions 5.90
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -14.490
EPS Est. Current Year -0.780
EPS Est. Next Year -0.640
EPS Est. Next Quarter -0.170
Forward EPS -0.460
Book Value (p.s.) 0.730
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -128.2
Return on Equity (ttm) -156.9
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -13.43
Levered Free Cash Flow (M) -8.09

Stock Valuations

P/E -0.10
P/E Growth Ratio -0.01
P/BV 1.93
P/CF -0.98

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2018-04-17
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.